Here we investigated for the first time the gene expression profile of four genes (EGFR, CDK4, MDM4, and PDGFRA) most frequently amplified at the DNA level in GBM [4] and its potential association with both underlying gene amplification and/or intragenic deletions, and patient outcome. Here, PDGFRA is linked to glioblastoma.